Interested in promotions? | Click here >>
PTPN13 Phosphatase
Experimental Controls

PTPN13 Phosphatase #8008

Citations (0)
PTPN13 Phosphatase: Image 1

Figure 1. The purity of the GST-PTPN13 fusion protein was analyzed using SDS/PAGE followed by Coomassie stain.

PTPN13 Phosphatase: Image 2

Figure 2. PTPN13 phosphatase activity was measured in a DELFIA® assay using the following reaction conditions: 25 mM HEPES, pH 7.2, 50 mM NaCl, 2.5 mM EDTA, 5 mM DTT, 65 ng/μl BSA, Substrate: Phospho-Poly (Glu-Tyr) Biotinylated Peptide #1586 at 1.5 μM, and 0.06 ng/μl PTPN13.

Product Description

Purified recombinant human PTPN13 (Asp2169-Lys2485) Phosphatase, supplied as a GST fusion protein.

MW (kDa) 61000


Enzyme is supplied in 20 mM MOPS, pH7.5; 50 mM NaCl, 0.25 mM DTT, 0.1 mM PMSF, 30% glycerol, 7 mM glutathione.Store at -80° C.Keep on ice during use.Avoid repeated freeze-thaw cycles.

Quality Control

The theoretical molecular weight of the GST-PTPN13 fusion protein is 61 kDa. The purified phosphatase was quality controlled for purity using SDS-PAGE followed by Coomassie stain [Fig.1]. PTPN13 Phosphatase activity was determined using a DELFIA(R) assay [Fig.2].

Source / Purification

The GST-phosphatase fusion protein was produced by expressing recombinant human PTPN13 (Asp2169-Lys2485) (GenBank Accession No. NM_080683) with an amino-terminal GST tag in E. coli. The protein was purified by one-step affinity chromatography using glutathione-agarose.


Non-receptor protein tyrosine phosphatase 13 (PTPN13) is also known as Fas-associated phosphatase-1 (FAP-1) because it associates with the regulatory domain of the Fas receptor and negatively regulates Fas signaling (1). PTPN13 protein contains: an N-terminal kinase non-catalytic C-lobe domain (KIND); followed by a Four-point-one/Ezrin/Radixin/Moesin (FERM) domain; five PDZ domains; and a C-terminal phosphatase domain (2,3). The function of the KIND domain is not clear, while the FERM domain is thought to bind cell surface receptors and help target PTPN13 to the plasma membrane. The PDZ domains may help PTPN13 bind selectively to target proteins and maintain substrate specificity (2). Dephosphorylation of Fas receptor by PTPN13 reduces the presence of the receptor at the cell surface and inhibits Fas-mediated apoptosis (4). Both Fas receptor and its inhibitor are regulated through NF-κB signaling. Activated Fas receptor induces NF-κB signaling, which promotes expression of the Fas inhibitor PTPN13 (5). Induced overexpression of PTPN13 in vitro blocks IRS-1/PI3K/Akt signaling by dephosphorylating IRS-1, leading to reduced cell survival and induction of apoptosis (6). Mutations in the corresponding PTPN13 gene and abnormal phosphatase activity are associated with colorectal cancer, suggesting that PTPN13 plays an important role in regulating cancer cell proliferation (7). Similar studies indicate that PTPN13 may act as a tumor suppressor in hepatocellular carcinoma as inhibition of PTPN13 phosphatase activity results in increased cancer cell proliferation (8).

  1. Sato, T. et al. (1995) Science 268, 411-5.
  2. Erdmann, K.S. (2003) Eur J Biochem 270, 4789-98.
  3. Saras, J. et al. (1994) J Biol Chem 269, 24082-9.
  4. Ivanov, V.N. et al. (2003) Mol Cell Biol 23, 3623-35.
  5. Ivanov, V.N. et al. (2006) J Biol Chem 281, 1840-52.
  6. Dromard, M. et al. (2007) Cancer Res 67, 6806-13.
  7. Wang, Z. et al. (2004) Science 304, 1164-6.
  8. Yeh, S.H. et al. (2006) Clin Cancer Res 12, 1097-108.

Pathways & Proteins

Explore pathways + proteins related to this product.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST's products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST's Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
DELFIA is a registered trademark of PerkinElmer, Inc.
Inquiry Info.# 8008